NON-EXCLUSIVE DISTRIBUTION AGREEMENTNon-Exclusive Distribution Agreement • April 23rd, 2004 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledApril 23rd, 2004 Company IndustryTHIS NON-EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”), dated as of February 9, 2004 (the “Effective Date”) is entered into between MediCult A/S (“Distributor”), CVR-no. 10975077, a Danish corporation, having a place of business located at Møllehaven 12, DK-4040 Jyllinge, Denmark, and HALOZYME THERAPEUTICS, INC. (“Halozyme”), a California corporation, having a principal place of business at 11588 Sorrento Valley Road, Suite 17, San Diego, CA 92121. The parties hereby agree as follows:
AGREEMENT FOR SERVICESAgreement for Services • April 23rd, 2004 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 23rd, 2004 Company Industry JurisdictionThis AGREEMENT FOR SERVICES is made this __ day of November, 2003 (the “Effective Date”) by and between Avid Bioservices, Inc., a Delaware corporation, (hereinafter referred to as “AVID”), having its principal office at 14282 Franklin Avenue, Tustin, CA 92780, USA and Hyalozyme Therapeutics, Inc, a California corporation, (hereinafter referred to as "COMPANY"), having its principal office at 11588 Sorrento Valley Road, Suite-17, San Diego, CA 92121, USA.
LICENSE AGREEMENT between the UNIVERSITY OF CONNECTICUT HEALTH CENTER and DELIATROPH PHARMACEUTICALS, INC.License Agreement • April 23rd, 2004 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledApril 23rd, 2004 Company Industry JurisdictionThis License Agreement, effective as of the 15th day of November, 2002 (the "EFFECTIVE DATE"), is between the University of Connecticut Health Center ("UCHC"), a public institution of higher education, c/o the Center for Science and Technology Commercialization, with a principal office at 263 Farmington Avenue, Farmington, CT 06030-6207, and DeliaTroph Pharmaceuticals, Inc. ("DELIATROPH"), a California Corporation, with a principal place of business at 11588 Sorrento Valley Road, Suite 16, San Diego, CA 92121.
NON-EXCLUSIVE DISTRIBUTION AGREEMENTNon-Exclusive Distribution Agreement • April 23rd, 2004 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledApril 23rd, 2004 Company IndustryTHIS NON-EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”), dated as of April 13, 2004 (the “Effective Date”) is entered into between COOK OB/GYN INCORPORATED (“Distributor”), an Indiana corporation, having a place of business located at 1100 West Morgan Street, Spencer, Indiana 47460, and HALOZYME THERAPEUTICS, INC. (“Halozyme”), a California corporation, having a principal place of business at 11588 Sorrento Valley Road, Suite 17, San Diego, CA 92121. The parties hereby agree as follows: